Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
Heecap has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Heecap's investors include CDTI Innovacion's INNVIERTE program, ICF - Institut Catalae de Finances, Nara Capital.
Heecap is headquartered in Barcelona, Spain.
Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
Heecap is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heecap — Funding & Investors." VCBacked, December 9, 2024, https://www.vcbacked.co/company/heecap. Accessed July 18, 2026.
VCBacked. (2024). Heecap — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/heecap
{{cite web |title=Heecap — Funding & Investors |url=https://www.vcbacked.co/company/heecap |website=VCBacked |access-date=July 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated